Skip to main content

Published locations for Vemurafenib granted sNDA, priority review for Erdheim-Chester disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Vemurafenib granted sNDA, priority review for Erdheim-Chester disease

User login

  • Reset your password
  • /content/vemurafenib-granted-snda-priority-review-erdheim-chester-disease
  • /hematologynews/article/144120/myelodysplastic-syndrome/vemurafenib-granted-snda-priority-review
  • /hematology-oncology/article/144120/myelodysplastic-syndrome/vemurafenib-granted-snda-priority-review